CAR T-Cell Therapy is an innovative form of immunotherapy that involves modifying a patient’s T-cells to express a Chimeric Antigen Receptor (CAR) which enables them to target and destroy cancer cells. This therapy has shown remarkable success in treating certain types of blood cancers and is now being explored for its potential in treating gynecologic cancers.
